Czech National Bank Has $4.36 Million Stake in The Clorox Company (NYSE:CLX)

Czech National Bank raised its stake in The Clorox Company (NYSE:CLX - Free Report) by 6.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 26,839 shares of the company's stock after acquiring an additional 1,607 shares during the period. Czech National Bank's holdings in Clorox were worth $4,359,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in CLX. Graypoint LLC raised its position in Clorox by 9.5% in the 4th quarter. Graypoint LLC now owns 4,269 shares of the company's stock valued at $693,000 after purchasing an additional 370 shares during the last quarter. ST Germain D J Co. Inc. grew its stake in shares of Clorox by 7.5% during the fourth quarter. ST Germain D J Co. Inc. now owns 4,281 shares of the company's stock valued at $695,000 after purchasing an additional 300 shares during the last quarter. Wealth Enhancement Advisory Services LLC increased its holdings in shares of Clorox by 1.2% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 46,309 shares of the company's stock valued at $7,544,000 after purchasing an additional 532 shares in the last quarter. Range Financial Group LLC raised its position in Clorox by 223.1% in the 4th quarter. Range Financial Group LLC now owns 4,972 shares of the company's stock worth $808,000 after purchasing an additional 3,433 shares during the last quarter. Finally, Canandaigua National Bank & Trust Co. lifted its holdings in Clorox by 12.9% during the 4th quarter. Canandaigua National Bank & Trust Co. now owns 9,991 shares of the company's stock worth $1,623,000 after buying an additional 1,145 shares in the last quarter. 78.53% of the stock is owned by institutional investors.

Clorox Trading Up 1.4 %

Shares of CLX traded up $2.20 during trading hours on Thursday, reaching $160.50. The stock had a trading volume of 871,212 shares, compared to its average volume of 955,991. The company has a market cap of $19.87 billion, a P/E ratio of 55.92, a P/E/G ratio of 2.90 and a beta of 0.42. The Clorox Company has a 52 week low of $127.60 and a 52 week high of $171.37. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08. The firm has a 50-day moving average of $164.40 and a 200 day moving average of $156.17.

Clorox (NYSE:CLX - Get Free Report) last announced its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The company had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.64 billion. During the same period in the prior year, the company earned $0.49 earnings per share. The company's revenue for the quarter was up 27.0% compared to the same quarter last year. On average, sell-side analysts expect that The Clorox Company will post 6.87 earnings per share for the current fiscal year.

Clorox Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be paid a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a yield of 3.04%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox's payout ratio is currently 170.03%.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on CLX. DA Davidson boosted their target price on Clorox from $153.00 to $171.00 and gave the stock a "neutral" rating in a research report on Monday, November 4th. Barclays boosted their price objective on Clorox from $137.00 to $139.00 and gave the stock an "underweight" rating in a report on Friday, November 1st. TD Cowen raised shares of Clorox from a "sell" rating to a "hold" rating and raised their target price for the company from $155.00 to $170.00 in a research note on Wednesday, November 6th. StockNews.com cut shares of Clorox from a "buy" rating to a "hold" rating in a research report on Sunday, January 5th. Finally, Wells Fargo & Company upgraded shares of Clorox from an "underweight" rating to an "equal weight" rating and increased their price objective for the company from $155.00 to $157.00 in a report on Tuesday, January 7th. Four investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus target price of $157.23.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.